Swiss Dermatology Network of Targeted Therapies (SDNTT)

NCT01706692 · clinicaltrials.gov ↗

RECRUITING

Status

1121

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

BIOLOGICAL: Adalimumab
BIOLOGICAL: Etanercept
BIOLOGICAL: Infliximab
BIOLOGICAL: Ustekinumab
DRUG: Cyclosporine A
DRUG: Fumaric acids
DRUG: Methotrexate
DRUG: Other anti-psoriatic systemic treatments

Sponsor

Swiss Dermatology Network for Targeted Therapies